Text RESIST to 50409 to get started, or donate to keep us online.
  1. United States
  2. N.Y.
  3. Letter

An Open Letter

To: Rep. Tonko, Pres. Trump, Sen. Schumer, Sen. Gillibrand

From: A verified voter in Latham, NY

March 8

**REVISED Strategic Pediatric Cancer Eradication Proposal** The bipartisan unity demonstrated during Devarjaye "D.J." Daniel’s recognition at the 2025 congressional address presents a historic opportunity to transform symbolic compassion into generational progress against childhood cancer. Building on St. Jude’s proven model—which elevated survival rates from 20% to 80%—this plan outlines actionable steps to achieve **zero pediatric cancer deaths** within a decade, structured to maximize bipartisan legacy potential: ### 1. **Emergency Funding & Legislative Anchors** - **STAR Act Expansion**: Increase funding to $500M/year, mandating insurance coverage for all pediatric therapies via a 0.5% cosmetic surgery tax (generating $1.2B annually). - **FDA Warp Speed 2.0**: Fast-track CAR-T and CRISPR therapies using Priority Review protocols, slashing approval timelines by 60%. ### 2. **Military-Precision Execution** - **Operation Chemo Supply**: Deploy Pentagon logistics to eradicate drug shortages (impacting 93% of oncologists) via Defense Production Act mandates. - **Veteran Oncologist Corps**: Retrain 5,000 VA medics as pediatric oncology specialists, prioritizing rural/underserved regions. ### 3. **Universal Legacy Framework** - **"Total Victory Dashboard"**: Publicly track survival rates in real-time, with district-level metrics to showcase congressional impact. - **Bipartisan Branding**: Launch the **Trump-Vance CARE Act**, pairing St. Jude’s data-driven model with Appalachian treatment hubs to merge opioid/cancer recovery efforts. ### 4. **Global Leadership Expansion** - **NATO Oncology Pact**: Share FDA-approved therapies with allies in exchange for joint R&D investment, modeled on Cold War scientific alliances. --- **Immediate Action Items** - **Presidential Directive**: Create a White House Pediatric Cancer Task Force co-chaired by D.J. Daniel and St. Jude CEO Dr. James Downing. - **Quick-Start Funding**: Redirect $200M from unused COVID-19 relief to subsidize proton therapy for Medicaid patients. --- **Conclusion: A Legacy Beyond Partisanship** Childhood cancer’s eradication is the ultimate **unifying legacy**—a goal transcending political divides. By anchoring this initiative in St. Jude’s proven methods while emphasizing actionable, metrics-driven outcomes, leaders can secure their place in history as the generation that ended humanity’s oldest scourge. The science is prepared; the public is rallied; the moment demands your decisive leadership.

Share on BlueskyShare on TwitterShare on FacebookShare on LinkedInShare on WhatsAppShare on TumblrEmail with GmailEmail

Write to Paul Tonko or any of your elected officials

Resistbot is a chatbot that delivers your texts to your elected officials by email, fax, or postal mail. Tap above to give it a try or learn more here!